Thank you for visiting the Ryman Healthcare Limited (Ryman) pro-rata accelerated non-renounceable entitlement offer website.

The Retail Entitlement Offer has now closed.

The Entitlement Offer

The Entitlement Offer is an offer of New Shares under a pro-rata accelerated non-renounceable entitlement offer (referred to as an ANREO). Under the Entitlement Offer, Eligible Shareholders have an entitlement to subscribe for 1 New Share for every 3.05 Existing Shares held as at the Record Date (being 5.00pm (NZDT) on Tuesday, 25 February 2025) at the Offer Price. 

The number of Entitlements to which an Eligible Shareholder is entitled to be issued will, in the case of fractions, be rounded down to the nearest whole number. Entitlements are not rounded up to a minimum holding. 

The New Shares issued under the Offer will be the same class as, and will rank equally with, Existing Shares which are quoted on the NZX Main Board.  Ryman will take any necessary steps to ensure that the New Shares are, immediately after issue, quoted on the NZX Main Board.

The Entitlement Offer is a non-renounceable offer. Eligible Shareholders may take up all, part or none of their Entitlements. Eligible Shareholders who take up their Entitlements in full may apply for Additional New Shares, up to a maximum amount of Additional New Shares equal to 75% of their Entitlement. An Eligible Shareholder who takes up their Entitlements in full and is allocated additional New Shares (either in the Placement or as part of the over-subscriptions under the Retail Entitlement Offer) equal to at least 46% of their Entitlements, will not be diluted as a result of the Offer.

Eligible Shareholders who do not take up any of their Entitlements or receive any Shares under the Placement and Ineligible Shareholders will have their shareholding in Ryman diluted by approximately 32% as a result of the Offer. Even Eligible Shareholders who take up their Entitlements in full (but do not receive any Shares under the Placement or under the oversubscription facility), will have their shareholding in Ryman diluted by approximately 10% as a consequence of the Placement. No value will be received for Entitlements that are not taken up.

Offer Size

Ryman expects to raise approximately NZ$688 million (before costs) through the Entitlement Offer (as part of a total Offer size of approximately NZ$1 billion), which is fully underwritten by the Underwriters.

The approximate number of New Shares being offered under the Offer is 328 million New Shares, representing approximately 47.7% of the Existing Shares. 

Offer Price

The Offer Price is NZ$3.05 per New Share and must be paid in full on application.

Payment of the Offer Price must be made in accordance with the online application process.

Important notice and disclaimer

Click here to see the Important Notice and Disclaimer in respect of the Offer.